{"id":6465,"date":"2022-05-26T10:00:41","date_gmt":"2022-05-26T10:00:41","guid":{"rendered":"https:\/\/www.rednovius.com\/?p=6465"},"modified":"2022-12-15T15:06:34","modified_gmt":"2022-12-15T15:06:34","slug":"pharma-landscape","status":"publish","type":"post","link":"https:\/\/www.rednovius.com\/pharma-landscape\/","title":{"rendered":"A \u2018New Not-Normal\u2019 Landscape after COVID: What does it Mean for Pharma?"},"content":{"rendered":"\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https:\/\/www.rednovius.com\/book-expert-session\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"683\" src=\"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?resize=1024%2C683&#038;ssl=1\" alt=\"A \u2018new not-normal\u2019 after COVID: what does it mean for pharma?\" class=\"wp-image-6874\" srcset=\"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?resize=1024%2C683&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?resize=300%2C200&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?resize=768%2C512&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?resize=900%2C600&amp;ssl=1 900w, https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?w=1200&amp;ssl=1 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" data-recalc-dims=\"1\" \/><\/a><\/figure><\/div>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">The plans are being set by many pharma companies about what comes after the pandemic. In what sense can this upcoming \u201cnew not-normal\u201d affect the way many know the pharma industry? What will be the main changes that pharma companies have to adapt to?<\/span> The pharma landscape as we knew it has changed. Dive on in to learn more about this new normal.<\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 class=\"has-text-align-center wp-block-heading\" style=\"font-size:46px\">A walk toward a new pharma landscape<\/h2>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">For many pharma and medical marketers, there was a consensus on the pandemic: the pharma landscape has changed. COVID introduced them to good and bad possibilities. The good news? The fact that a public health crisis helped them prepare and face new challenges in healthcare.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">But what about the bad news? The fact that this crisis shook the health industry. The fact that this was not an industry known for quick adaptation led to some complications and crises along the way.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">There are many contributing elements to this change,<\/span> which has already started affecting Pfizer. Recently,<span style=\"font-weight: 400;\"> the pharma company announced that it would reduce its US sales force. All due to an expectation \u201cthat healthcare providers will want fewer face-to-face interactions with reps even after the pandemic ends,&#8221; according to MM+M in a detailed article that showed the perspective of many industry leaders on the shift taking place.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">This same source goes even deeper into<\/span> the fact that pharma will become more and more digital. Some of the main topics that marked the beginning of this switch <span style=\"font-weight: 400;\">for the past two years of the pandemic were:<\/span><\/p>\n\n\n\n<ul><li><span style=\"font-weight: 400;\">The changing role of pharma\u2019s sales reps;<\/span><\/li><li><span style=\"font-weight: 400;\">The increasing consumerization and personalization of health;<\/span><\/li><li><span style=\"font-weight: 400;\">The breaking down of silos to be more agile;<\/span><\/li><li><span style=\"font-weight: 400;\">The development of new technologies to help speed up all the previous factors.<\/span><\/li><\/ul>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"has-text-align-center wp-block-heading\" style=\"font-size:46px\">The lasting effect of COVID on pharma interactions<\/h3>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">There&#8217;s a tendency for many interactions between sales reps and physicians to become more digital. The sales rep\u2019s role today is quite different from two years ago. Now, like physicians, they need to have good knowledge of many healthcare topics. Not to mention that they need digital tools to provide a personalized experience to their contacts.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Patients are also becoming more and more demanding of their digital experiences. They are looking for more connected experiences and services. For healthcare providers, this will increase their demands for access to real-time tools and support.\u00a0<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">In turn, this pushes the role of the reps to a whole new level. <\/span>In fact, n<span style=\"font-weight: 400;\">o longer are they the main orchestrators of the entire funnel of relationship management. More than passing and selling a message, they have to provide an experience to their stakeholders.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Right now, remote interactions have increased in popularity and preference for many HCPs. Yet it involves more than a remote, hybrid, or in-person interaction. It involves a deeper understanding of the needs and behaviors of the people you&#8217;re communicating with.\u00a0<\/span><\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"has-text-align-center wp-block-heading\" style=\"font-size:46px\">Omnichannel pharma is here to stay<\/h3>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">Of course, for many professionals who saw this coming, everything points to the concept of omnichannel in pharma. Now it stopped being a mere buzzword and became the unfolding reality for the industry. Even in a post-pandemic world, this is the remaining \u201cscar\u201d that will shape pharma from now onwards.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">There are three main reasons why this happened, though:<\/span><\/p>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<ol><li> <strong style=\"font-size: revert; color: initial;\">Thanks to the pandemic the world went through, pharma could no longer operate the way it used to.<\/strong><span style=\"font-size: revert; color: initial;\"> Many pharma companies are still having difficulties when it comes to old habits, but the new panorama will force the change;<\/span> <\/li><li> <strong style=\"font-size: revert; color: initial;\">New expectations from consumers need pharma companies to be more agile.<\/strong><span style=\"font-size: revert; color: initial;\"> Hence why elements such as targeted messaging, effective follow-up, and sustained conversations were essential to making this agility possible;<\/span> <\/li><li> <strong style=\"font-size: revert; color: initial;\">It would only be a matter of time for technology users around marketing for a couple of years to start approaching pharma.<\/strong><span style=\"font-size: revert; color: initial;\"> Elements such as Web 3.0, AI-powered chatbots, blockchain and augmented and virtual reality are gaining many healthcare marketers\u2019 attention.<\/span> <\/li><\/ol>\n\n\n\n<p><\/p>\n\n\n\n<p>Interactions in pharma have changed. Generally speaking, this means there&#8217;s a higher demand for quality content from healthcare professionals and patients alike. <\/p>\n\n\n\n<blockquote class=\"wp-block-quote has-text-align-center\"><p><b>RedNovius has the solution for you: with <a href=\"https:\/\/www.rednovius.com\">PubVisual<\/a>, you can provide a personalized 90-second video to explain your medical data to anyone<\/b>. <b><a href=\"https:\/\/www.rednovius.com\/book-expert-session\/\">Book a meeting<\/a> and discover how we can help you.<\/b><\/p><\/blockquote>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"has-text-align-center wp-block-heading\" style=\"font-size:46px\">Faster and easier: This is the new way for pharma<\/h3>\n\n\n\n<div style=\"height:25px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p><span style=\"font-weight: 400;\">The increased use of e-commerce influenced the marketing of healthcare products and services to meet their standards. In fact, it\u2019s a golden opportunity for pharma to start listening to what their customers want as a way to start a dialogue. According to Marcos Mendell, EVP for health platform innovation at Real Chemistry, \u201cthe way that we\u2019re restructuring content is to create interest and a dialogue.\u201d<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Telehealth\u2019s future role may still be a little blurry in many countries, but it influenced the personalization need felt by many pharma companies right now. Some companies allow their patients to contact a doctor with the mere push of a button.\u00a0<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Without a doubt, many customer-centric models of interaction will, in no time, become the norm and not the exception. As the president of McCann Health Engagement, Jeffrey Erb puts it, \u201cBrands that interact with people, versus patients, will find those efforts rewarded.\u201d<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">An upcoming constraint is the matter of privacy and the appropriate use of online behavioral data. In addition, there are more state-specific privacy regulations and industry standards rising to assure data protection. I<\/span>n essence, m<span style=\"font-weight: 400;\">any companies will have to stop relying on third-party data for them to understand, target, and personalize their content for patients and HCPs.<\/span><\/p>\n\n\n\n<p><span style=\"font-weight: 400;\">Pharma,<\/span> as many knew it, has changed. Though there is a minority that wishes to go back to \u201cthe good old days,&#8221; <span style=\"font-weight: 400;\">the majority of people are facing the present: the pharma landscape has changed and things will never be the same again.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Looking at the latest numbers, conclusions for improvement can be reached. Through this, knowledgeable decision&#8230;<\/p>\n","protected":false},"author":2,"featured_media":6874,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","om_disable_all_campaigns":false,"inline_featured_image":false,"footnotes":""},"categories":[58,51],"tags":[109,100,111,110,112],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>What is Pharma&#039;s &#039;New Not-Normal&#039; landscape? | RedNovius<\/title>\n<meta name=\"description\" content=\"Learn more about the new pharma landscape being pushed by the challenging and disruptive impact of COVID-19.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rednovius.com\/pharma-landscape\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What is Pharma&#039;s &#039;New Not-Normal&#039; landscape? | RedNovius\" \/>\n<meta property=\"og:description\" content=\"Learn more about the new pharma landscape being pushed by the challenging and disruptive impact of COVID-19.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rednovius.com\/pharma-landscape\/\" \/>\n<meta property=\"og:site_name\" content=\"RedNovius | Digital Pharma Marketing Company\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-26T10:00:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-12-15T15:06:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Bosko F\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Bosko F\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.rednovius.com\/pharma-landscape\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.rednovius.com\/pharma-landscape\/\"},\"author\":{\"name\":\"Bosko F\",\"@id\":\"https:\/\/www.rednovius.com\/#\/schema\/person\/599decddc49ff43142e6f2fb38cf5f61\"},\"headline\":\"A \u2018New Not-Normal\u2019 Landscape after COVID: What does it Mean for Pharma?\",\"datePublished\":\"2022-05-26T10:00:41+00:00\",\"dateModified\":\"2022-12-15T15:06:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.rednovius.com\/pharma-landscape\/\"},\"wordCount\":982,\"publisher\":{\"@id\":\"https:\/\/www.rednovius.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.rednovius.com\/pharma-landscape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?fit=1200%2C800&ssl=1\",\"keywords\":[\"covid and pharma industry\",\"covid and pharmaceutical industry\",\"covid interactions\",\"omnichannel marketing in pharmaceutical industry\",\"pharma industry challenges\"],\"articleSection\":[\"Omnichannel Marketing\",\"Pharma Challenges\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rednovius.com\/pharma-landscape\/\",\"url\":\"https:\/\/www.rednovius.com\/pharma-landscape\/\",\"name\":\"What is Pharma's 'New Not-Normal' landscape? | RedNovius\",\"isPartOf\":{\"@id\":\"https:\/\/www.rednovius.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.rednovius.com\/pharma-landscape\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.rednovius.com\/pharma-landscape\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?fit=1200%2C800&ssl=1\",\"datePublished\":\"2022-05-26T10:00:41+00:00\",\"dateModified\":\"2022-12-15T15:06:34+00:00\",\"description\":\"Learn more about the new pharma landscape being pushed by the challenging and disruptive impact of COVID-19.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.rednovius.com\/pharma-landscape\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rednovius.com\/pharma-landscape\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rednovius.com\/pharma-landscape\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?fit=1200%2C800&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?fit=1200%2C800&ssl=1\",\"width\":1200,\"height\":800,\"caption\":\"A \u2018new not-normal\u2019 after COVID: what does it mean for pharma?\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rednovius.com\/pharma-landscape\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rednovius.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"A \u2018New Not-Normal\u2019 Landscape after COVID: What does it Mean for Pharma?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rednovius.com\/#website\",\"url\":\"https:\/\/www.rednovius.com\/\",\"name\":\"RedNovius | Digital Pharma Marketing Company\",\"description\":\"Digital Pharma Marketing Company\",\"publisher\":{\"@id\":\"https:\/\/www.rednovius.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rednovius.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.rednovius.com\/#organization\",\"name\":\"RedNovius | Digital Pharma Marketing Company\",\"url\":\"https:\/\/www.rednovius.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rednovius.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.rednovius.com\/wp-content\/uploads\/2018\/11\/logo-dark.png\",\"contentUrl\":\"https:\/\/www.rednovius.com\/wp-content\/uploads\/2018\/11\/logo-dark.png\",\"width\":400,\"height\":60,\"caption\":\"RedNovius | Digital Pharma Marketing Company\"},\"image\":{\"@id\":\"https:\/\/www.rednovius.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rednovius.com\/#\/schema\/person\/599decddc49ff43142e6f2fb38cf5f61\",\"name\":\"Bosko F\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rednovius.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8c0152cd6c3cc5df4de2990a1ee4a5c6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8c0152cd6c3cc5df4de2990a1ee4a5c6?s=96&d=mm&r=g\",\"caption\":\"Bosko F\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"What is Pharma's 'New Not-Normal' landscape? | RedNovius","description":"Learn more about the new pharma landscape being pushed by the challenging and disruptive impact of COVID-19.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rednovius.com\/pharma-landscape\/","og_locale":"en_US","og_type":"article","og_title":"What is Pharma's 'New Not-Normal' landscape? | RedNovius","og_description":"Learn more about the new pharma landscape being pushed by the challenging and disruptive impact of COVID-19.","og_url":"https:\/\/www.rednovius.com\/pharma-landscape\/","og_site_name":"RedNovius | Digital Pharma Marketing Company","article_published_time":"2022-05-26T10:00:41+00:00","article_modified_time":"2022-12-15T15:06:34+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png","type":"image\/png"}],"author":"Bosko F","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Bosko F","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rednovius.com\/pharma-landscape\/#article","isPartOf":{"@id":"https:\/\/www.rednovius.com\/pharma-landscape\/"},"author":{"name":"Bosko F","@id":"https:\/\/www.rednovius.com\/#\/schema\/person\/599decddc49ff43142e6f2fb38cf5f61"},"headline":"A \u2018New Not-Normal\u2019 Landscape after COVID: What does it Mean for Pharma?","datePublished":"2022-05-26T10:00:41+00:00","dateModified":"2022-12-15T15:06:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rednovius.com\/pharma-landscape\/"},"wordCount":982,"publisher":{"@id":"https:\/\/www.rednovius.com\/#organization"},"image":{"@id":"https:\/\/www.rednovius.com\/pharma-landscape\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?fit=1200%2C800&ssl=1","keywords":["covid and pharma industry","covid and pharmaceutical industry","covid interactions","omnichannel marketing in pharmaceutical industry","pharma industry challenges"],"articleSection":["Omnichannel Marketing","Pharma Challenges"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rednovius.com\/pharma-landscape\/","url":"https:\/\/www.rednovius.com\/pharma-landscape\/","name":"What is Pharma's 'New Not-Normal' landscape? | RedNovius","isPartOf":{"@id":"https:\/\/www.rednovius.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rednovius.com\/pharma-landscape\/#primaryimage"},"image":{"@id":"https:\/\/www.rednovius.com\/pharma-landscape\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?fit=1200%2C800&ssl=1","datePublished":"2022-05-26T10:00:41+00:00","dateModified":"2022-12-15T15:06:34+00:00","description":"Learn more about the new pharma landscape being pushed by the challenging and disruptive impact of COVID-19.","breadcrumb":{"@id":"https:\/\/www.rednovius.com\/pharma-landscape\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rednovius.com\/pharma-landscape\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rednovius.com\/pharma-landscape\/#primaryimage","url":"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?fit=1200%2C800&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?fit=1200%2C800&ssl=1","width":1200,"height":800,"caption":"A \u2018new not-normal\u2019 after COVID: what does it mean for pharma?"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rednovius.com\/pharma-landscape\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rednovius.com\/"},{"@type":"ListItem","position":2,"name":"A \u2018New Not-Normal\u2019 Landscape after COVID: What does it Mean for Pharma?"}]},{"@type":"WebSite","@id":"https:\/\/www.rednovius.com\/#website","url":"https:\/\/www.rednovius.com\/","name":"RedNovius | Digital Pharma Marketing Company","description":"Digital Pharma Marketing Company","publisher":{"@id":"https:\/\/www.rednovius.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rednovius.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rednovius.com\/#organization","name":"RedNovius | Digital Pharma Marketing Company","url":"https:\/\/www.rednovius.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rednovius.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.rednovius.com\/wp-content\/uploads\/2018\/11\/logo-dark.png","contentUrl":"https:\/\/www.rednovius.com\/wp-content\/uploads\/2018\/11\/logo-dark.png","width":400,"height":60,"caption":"RedNovius | Digital Pharma Marketing Company"},"image":{"@id":"https:\/\/www.rednovius.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.rednovius.com\/#\/schema\/person\/599decddc49ff43142e6f2fb38cf5f61","name":"Bosko F","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rednovius.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8c0152cd6c3cc5df4de2990a1ee4a5c6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8c0152cd6c3cc5df4de2990a1ee4a5c6?s=96&d=mm&r=g","caption":"Bosko F"}}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.rednovius.com\/wp-content\/uploads\/2022\/05\/A-new-not-normal-after-COVID-what-does-it-mean-for-pharma_1.png?fit=1200%2C800&ssl=1","_links":{"self":[{"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/posts\/6465"}],"collection":[{"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/comments?post=6465"}],"version-history":[{"count":12,"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/posts\/6465\/revisions"}],"predecessor-version":[{"id":9543,"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/posts\/6465\/revisions\/9543"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/media\/6874"}],"wp:attachment":[{"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/media?parent=6465"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/categories?post=6465"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rednovius.com\/wp-json\/wp\/v2\/tags?post=6465"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}